ReviewFrontiers in oncology2026

Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma.

Giuseppe Bertuglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.